Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.26 USD
Change Today +0.045 / 2.04%
Volume 138.6K
SYN On Other Exchanges
As of 10:53 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

C. Evan Ballantyne

AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 6 different industries.

As of Fiscal Year 2014


Mr. C. Evan Ballantyne has been Chief Financial Officer of Agenus Inc. since June 2015. Mr. Ballantyne is responsible for all aspects of financial, accounting, investor relations and corporate communication functions. He served as the Chief Financial Officer and Executive Vice President at Trovis Pharmaceuticals LLC from August 2006 to April 2011. Mr. Ballantyne has more than 30 years of financial and operations experience. Mr. Ballantyne served as Principal Accounting ...

Read Full Background

Corporate Headquarters*

155 Gibbs Street
Rockville, Maryland 20850

United States

Phone: 734-332-7800
Fax: 734-332-7878

Board Members Memberships*

There is no Board Members Memberships data available.


The University Of Western Ontario
Master's Degree
University Of Windsor

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SYN:US $2.26 USD +0.045


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SYNTHETIC BIOLOGICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at